{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:10:27Z","timestamp":1789783827717,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1097\/shk.0000000000000050","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T12:36:11Z","timestamp":1380717371000},"page":"492-495","source":"Crossref","is-referenced-by-count":49,"title":["High-Mobility Group Box 1 Mediates Persistent Splenocyte Priming in Sepsis Survivors"],"prefix":"10.1097","volume":"40","author":[{"given":"Sergio I.","family":"Vald\u00e9s-Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Rosas-Ballina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder S.","family":"Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"Dancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianHua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin A.","family":"Pavlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta S.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"R1-8-20210213","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"16","key":"R2-8-20210213","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000.","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"issue":"19","key":"R3-8-20210213","first-page":"1","article-title":"Deaths: final data for 2007.","volume":"58","author":"Xu","year":"2010","journal-title":"Natl Vital Stat Rep"},{"issue":"6","key":"R4-8-20210213","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1532-5415.2012.03989.x","article-title":"Population burden of long-term survivorship after severe sepsis in older Americans.","volume":"60","author":"Iwashyna","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"R5-8-20210213","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1097\/01.CCM.0000085178.80226.0B","article-title":"Long-term mortality and medical care charges in patients with severe sepsis.","volume":"31","author":"Weycker","year":"2003","journal-title":"Crit Care Med"},{"issue":"5","key":"R6-8-20210213","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/CCM.0b013e318170a405","article-title":"Determinants of long-term survival after intensive care.","volume":"36","author":"Williams","year":"2008","journal-title":"Crit Care Med"},{"issue":"1","key":"R7-8-20210213","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/cc8848","article-title":"Quality of life in the five years after intensive care: a cohort study.","volume":"14","author":"Cuthbertson","year":"2010","journal-title":"Crit Care"},{"issue":"2","key":"R9-8-20210213","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"HMGB1 signals through Toll-like receptor (TLR) 4 and TLR2.","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"issue":"3","key":"R10-8-20210213","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/SHK.0b013e318186262d","article-title":"Role of Toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.","volume":"31","author":"van Zoelen","year":"2009","journal-title":"Shock"},{"key":"R11-8-20210213","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection.","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"R12-8-20210213","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2119\/molmed.2012.00195","article-title":"HMGB1 mediates cognitive impairment in sepsis survivors.","volume":"18","author":"Chavan","year":"2012","journal-title":"Mol Med"},{"issue":"6","key":"R15-8-20210213","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/SHK.0b013e3181cd8c88","article-title":"Burn trauma induces early hmgb1 release in patients: its correlation with cytokines.","volume":"33","author":"Lantos","year":"2010","journal-title":"Shock"},{"issue":"1","key":"R16-8-20210213","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cyto.2010.09.010","article-title":"Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients.","volume":"53","author":"Huang","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"R17-8-20210213","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/01.CCM.0000155991.88802.4D","article-title":"Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock.","volume":"33","author":"Sunden-Cullberg","year":"2005","journal-title":"Crit Care Med"},{"issue":"4","key":"R18-8-20210213","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.mpa.0000236741.15477.8b","article-title":"Significant Increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis.","volume":"33","author":"Yasuda","year":"2006","journal-title":"Pancreas"},{"issue":"7-8","key":"R19-8-20210213","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2119\/molmed.2009.00039","article-title":"The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.","volume":"15","author":"Rosas-Ballina","year":"2009","journal-title":"Mol Med"},{"issue":"5","key":"R22-8-20210213","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2353\/ajpath.2007.060872","article-title":"Pathophysiology of sepsis.","volume":"170","author":"Remick","year":"2007","journal-title":"Am J Pathol"},{"issue":"6917","key":"R23-8-20210213","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature01326","article-title":"The immunopathogenesis of sepsis.","volume":"420","author":"Cohen","year":"2002","journal-title":"Nature"},{"issue":"2","key":"R24-8-20210213","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis.","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"R25-8-20210213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00024382-200302000-00004","article-title":"Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis.","volume":"19","author":"Rigato","year":"2003","journal-title":"Shock"},{"issue":"2","key":"R26-8-20210213","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/cc12596","article-title":"Impact of interleukin-10, soluble CD25 and interferon- on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study.","volume":"17","author":"Matera","year":"2013","journal-title":"Crit Care"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SHK.0000000000000050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:07:53Z","timestamp":1620972473000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00024382-201312000-00008"}},"subtitle":["Evidence From a Murine Model"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0000000000000050","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}